BRCA1 and breast carcinoma: In breast cancer cell lines with BRCA1 promoter methylation, low expression levels of BRCA1 mRNA and protein were observed, and these cell lines showed cisplatin sensitivity comparable to that of BRCA1 mutated cells [72].